William Bjornsson
Partner
Article
3
On Dec. 9, 2022, Health Canada announced the approval of the proposed amendments introduced by the Regulations Amending Certain Regulations Concerning Cannabis Research as well as the Order Amending Schedule 3 to the Cannabis Act.
These amendments increase the public possession limit for cannabis beverages, and facilitate non-therapeutic cannabis research and testing. Health Canada anticipates publishing the amendments in Canada Gazette Part II on Dec. 22, 2022.
The amendments are intended to provide increased consistency across cannabis product possession limits, and improve the regulation of research, testing, and analysis. Among other things, the amendments:
The amended regulations will include transition periods for existing licensed researchers and cannabis beverage producers.
Gowling WLG's Cannabis Group includes professionals with expertise in all matters cannabis law who can help you navigate this landscape and identify how your business can benefit from these changes.
NOT LEGAL ADVICE. Information made available on this website in any form is for information purposes only. It is not, and should not be taken as, legal advice. You should not rely on, or take or fail to take any action based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Gowling WLG professionals will be pleased to discuss resolutions to specific legal concerns you may have.
Gowling WLG is an international law firm comprising the members of Gowling WLG International Limited, an English Company Limited by Guarantee, and their respective affiliates. Each member and affiliate is an autonomous and independent entity. Gowling WLG International Limited promotes, facilitates and co-ordinates the activities of its members but does not itself provide services to clients. Our structure is explained in more detail on our Legal Information page.
© 2026 Gowling WLG All rights reserved.